What is the appropriate intratracheal epinephrine (adrenaline) dose for treating bronchospasm in infants, children, and adults?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Intratracheal Epinephrine for Bronchospasm: Dosing Recommendations

Intratracheal epinephrine is NOT the recommended route for treating bronchospasm—inhaled beta-agonists (nebulized albuterol) are first-line therapy, with intramuscular epinephrine reserved for anaphylaxis-associated bronchospasm. However, when intratracheal administration is necessary during cardiac arrest or in intubated patients with refractory bronchospasm, specific dosing applies.

Primary Treatment Algorithm for Bronchospasm

First-Line Therapy

  • Nebulized albuterol: 2.5-5 mg in 3 mL saline, repeat as necessary 1
  • This is the standard approach for bronchospasm resistant to adequate doses of epinephrine in anaphylaxis

When Intramuscular Epinephrine is Indicated

For bronchospasm associated with anaphylaxis:

  • Adults and children ≥4 years: 0.01 mg/kg of 1:1000 solution IM (maximum 0.3-0.5 mg)
  • Repeat every 5-20 minutes as needed 2
  • IM route in the lateral thigh is preferred over subcutaneous

Intratracheal (Endotracheal) Epinephrine Dosing

During Cardiopulmonary Resuscitation

When IV/IO access is unavailable:

Infants and Children:

  • 0.1 mg/kg of 1:1000 solution (0.1 mL/kg) 2, 3
  • Maximum dose: 2.5 mg 3
  • This is 10 times the IV dose of 0.01 mg/kg

Neonates:

  • 0.05-0.1 mg/kg via endotracheal tube 4
  • Higher dose needed compared to IV route (0.01-0.03 mg/kg IV)
  • Follow with saline flush (1-5 mL based on patient size)

For Refractory Post-Intubation Bronchospasm

Based on case evidence when standard therapies fail:

  • 0.5 mg of 1:10,000 epinephrine diluted in 10 mL normal saline administered via endotracheal tube 5
  • This represents an off-label, last-resort intervention for severe, refractory bronchospasm in intubated patients

Critical Dosing Principles

Why Higher Doses Are Required for Endotracheal Route

  • Bioavailability is significantly lower via endotracheal route compared to IV/IO 4, 6
  • Peak plasma concentrations occur at 5 minutes (vs. 1 minute for IV) 4
  • Standard IV doses given endotracheally can cause paradoxical hypotension due to unopposed beta-2 vasodilation 6
  • Research suggests 10-fold the IV dose (0.1 mg/kg vs 0.01 mg/kg) is needed to achieve therapeutic effect 6

Administration Technique

  • Dilute in isotonic saline (1-5 mL based on patient size) 2, 3
  • Follow with 5 mL normal saline flush and 5 positive-pressure ventilations 3
  • Stop chest compressions briefly during administration if CPR is in progress 3

Important Caveats and Pitfalls

Route Selection Hierarchy

  1. IV/IO epinephrine is always preferred when vascular access is available 4
  2. Endotracheal route is a temporizing measure while establishing vascular access
  3. Most patients require subsequent IV doses to achieve return of spontaneous circulation 4

Bronchospasm-Specific Considerations

  • Nebulized albuterol remains superior for isolated bronchospasm 1
  • Intratracheal epinephrine for bronchospasm is primarily supported by case reports 7, 5, not high-quality trials
  • The evidence base for epinephrine vs. selective beta-2 agonists in acute asthma shows similar efficacy but low quality evidence 8

Concentration Confusion Risk

  • 1:1000 (1 mg/mL) for endotracheal route in arrest: 0.1 mL/kg 2, 3
  • 1:10,000 (0.1 mg/mL) for IV route: 0.1 mL/kg (delivers 0.01 mg/kg) 2
  • Verify concentration before administration to prevent 10-fold dosing errors

Monitoring Requirements

  • Continuous pulse oximetry
  • Cardiac monitoring for arrhythmias
  • Blood pressure monitoring
  • Be prepared for potential adverse effects including tachycardia, hypertension, and arrhythmias

When NOT to Use Endotracheal Route

  • Never use for non-lipid-soluble drugs (sodium bicarbonate, calcium) 3
  • Avoid as first-line when IV/IO access is readily achievable
  • Not indicated for routine bronchospasm management outside of cardiac arrest or extreme refractory cases

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.